0.8122 USD
-0.02 (-2.39%)
0.83 USD
+0.02 (+2.19%)
We assign a fundamental rating of 3 out of 10 to DCGO. DCGO was compared to 102 industry peers in the Health Care Providers & Services industry. While DCGO has a great health rating, there are worries on its profitability. DCGO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- DCGO had negative earnings in the past year.
- DCGO had a positive operating cash flow in the past year.
- DCGO had positive earnings in 4 of the past 5 years.
- In multiple years DCGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
- With a Return On Assets value of -14.58%, DCGO is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
- DCGO's Return On Equity of -19.07% is on the low side compared to the rest of the industry. DCGO is outperformed by 63.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- DCGO's Profit Margin has declined in the last couple of years.
- DCGO's Operating Margin has declined in the last couple of years.
- With a decent Gross Margin value of 31.21%, DCGO is doing good in the industry, outperforming 60.78% of the companies in the same industry.
- In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
- DCGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, DCGO has less shares outstanding
- DCGO has a worse debt/assets ratio than last year.
2.2 Solvency
- DCGO has an Altman-Z score of 1.23. This is a bad value and indicates that DCGO is not financially healthy and even has some risk of bankruptcy.
- DCGO has a Altman-Z score of 1.23. This is in the lower half of the industry: DCGO underperforms 66.67% of its industry peers.
- The Debt to FCF ratio of DCGO is 0.32, which is an excellent value as it means it would take DCGO, only 0.32 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.32, DCGO belongs to the best of the industry, outperforming 93.14% of the companies in the same industry.
- DCGO has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of DCGO (0.04) is better than 81.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Altman-Z | 1.23 |
ROIC/WACCN/A
WACC8.57%
2.3 Liquidity
- A Current Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
- DCGO has a better Current ratio (2.59) than 82.35% of its industry peers.
- A Quick Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
- DCGO has a Quick ratio of 2.59. This is amongst the best in the industry. DCGO outperforms 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
- The earnings per share for DCGO have decreased strongly by -194.14% in the last year.
- The Earnings Per Share has been decreasing by -9.93% on average over the past years.
- The Revenue for DCGO has decreased by -47.03% in the past year. This is quite bad
- The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
3.2 Future
- The Earnings Per Share is expected to decrease by -42.21% on average over the next years. This is quite bad
- The Revenue is expected to decrease by -20.20% on average over the next years. This is quite bad
EPS Next Y-311.85%
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue Next Year-49.19%
Revenue Next 2Y-31.73%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for DCGO. In the last year negative earnings were reported.
- Also next year DCGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- DCGO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DCGO is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.53 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as DCGO's earnings are expected to decrease with -42.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
5. Dividend
5.1 Amount
- DCGO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
0.8122
-0.02 (-2.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners50.6%
Inst Owner Change-0.33%
Ins Owners9.01%
Ins Owner Change14.71%
Market Cap79.44M
Revenue(TTM)368.09M
Net Income(TTM)-51.59M
Analysts78.46
Price Target2.55 (213.96%)
Short Float %5.78%
Short Ratio6.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-14.37%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-85.28%
Min EPS beat(4)-311.74%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-44.96%
EPS beat(12)4
Avg EPS beat(12)-60.37%
EPS beat(16)7
Avg EPS beat(16)32.87%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)15.35%
PT rev (1m)-9.09%
PT rev (3m)-18.7%
EPS NQ rev (1m)-8.52%
EPS NQ rev (3m)-24.44%
EPS NY rev (1m)-13.68%
EPS NY rev (3m)-21.62%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.22 | ||
| P/FCF | 1.53 | ||
| P/OCF | 1.37 | ||
| P/B | 0.29 | ||
| P/tB | 0.38 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)0.53
FCFY65.25%
OCF(TTM)0.59
OCFY72.77%
SpS3.76
BVpS2.77
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% | ||
| FCFM | 14.08% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.73% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 1.23 |
F-Score4
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
EPS Next Y-311.85%
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
Revenue Next Year-49.19%
Revenue Next 2Y-31.73%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
EBIT growth 1Y-223.09%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-161.23%
EBIT Next 3Y-28.18%
EBIT Next 5YN/A
FCF growth 1Y168.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.23%
OCF growth 3YN/A
OCF growth 5YN/A
DOCGO INC / DCGO FAQ
What is the fundamental rating for DCGO stock?
ChartMill assigns a fundamental rating of 3 / 10 to DCGO.
What is the valuation status of DOCGO INC (DCGO) stock?
ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.
How profitable is DOCGO INC (DCGO) stock?
DOCGO INC (DCGO) has a profitability rating of 2 / 10.
What is the financial health of DOCGO INC (DCGO) stock?
The financial health rating of DOCGO INC (DCGO) is 7 / 10.